MR imaging features of amyloid-related imaging abnormalities.

Barakos, J; Sperling, R; Salloway, S; Jack, C; Gass, A; Fiebach, J B; Tampieri, D; Melançon, D; Miaux, Y; Rippon, G; Black, R; Lu, Y; Brashear, H R; Arrighi, H M; Morris, K A; Grundman, M

Barakos, J; Sperling, R; Salloway, S; Jack, C; Gass, A; Fiebach, J B; Tampieri, D; Melançon, D; Miaux, Y; Rippon, G; Black, R; Lu, Y; Brashear, H R; Arrighi, H M; Morris, K A; Grundman, M.

Affiliation

Barakos J; California Pacific Medical Center, San Francisco, California.

AJNR Am J Neuroradiol ; 34(10): 1958-65, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23578674

Subject(s)

Alzheimer Disease/drug therapy; Alzheimer Disease/pathology; Amyloidosis/chemically induced; Amyloidosis/pathology; Antibodies, Monoclonal, Humanized/adverse effects; Magnetic Resonance Imaging; Alzheimer Disease/epidemiology; Amyloid beta-Peptides/metabolism; Amyloidosis/epidemiology; Antibodies, Monoclonal, Humanized/administration & dosage; Brain/metabolism; Brain/pathology; Brain Edema/epidemiology; Brain Edema/pathology; Cerebral Hemorrhage/epidemiology; Cerebral Hemorrhage/pathology; Clinical Trials, Phase II as Topic; Gadolinium; Hemosiderin/metabolism; Humans; Incidence; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Alzheimer Disease / Antibodies, Monoclonal, Humanized / Amyloidosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: AJNR Am J Neuroradiol Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google